Scilia focuses on providing professional and comprehensive research services and solutions for pharmaceutical and biotech companies in the field of cell and gene therapy. 
Over the years, our scientists and engineers have developed and implemented several advanced automated platforms: CRISPR library screening platform, Virus vector platform,  cell line screening platform, high-throughput AI algorithm and single-cell in-depth analysis platform. 
Scilia is committed to working together with our customers to improve delivery time and reduce R&D risk and cost.